Literature DB >> 31698421

We didn't start the fire, MDSC inflammasome signaling in GVHD.

Nataliya Prokopenko Buxbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31698421      PMCID： PMC6871309          DOI： 10.1182/blood.2019003247

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.

Authors:  Brent H Koehn; Bruce R Blazar
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

2.  MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation.

Authors:  Sophia Chen; Benjamin A H Smith; Joseena Iype; Alessandro Prestipino; Dietmar Pfeifer; Sebastian Grundmann; Annette Schmitt-Graeff; Marco Idzko; Yvonne Beck; Gabriele Prinz; Jürgen Finke; Justus Duyster; Robert Zeiser
Journal:  Blood       Date:  2015-05-13       Impact factor: 22.113

Review 3.  Targeting the interleukin-1 pathway in patients with hematological disorders.

Authors:  Charlotte E M de Mooij; Mihai G Netea; Walter J F M van der Velden; Nicole M A Blijlevens
Journal:  Blood       Date:  2017-05-08       Impact factor: 22.113

Review 4.  Myeloid-Derived Suppressor Cells.

Authors:  Dmitry I Gabrilovich
Journal:  Cancer Immunol Res       Date:  2017-01       Impact factor: 11.151

5.  GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.

Authors:  Brent H Koehn; Petya Apostolova; Jessica M Haverkamp; Jeffrey S Miller; Valarie McCullar; Jakub Tolar; David H Munn; William J Murphy; Willie June Brickey; Jonathan S Serody; Dmitry I Gabrilovich; Vincenzo Bronte; Peter J Murray; Jenny P-Y Ting; Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2015-08-11       Impact factor: 22.113

6.  Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.

Authors:  Brent H Koehn; Asim Saha; Cameron McDonald-Hyman; Michael Loschi; Govindarajan Thangavelu; Lie Ma; Michael Zaiken; Josh Dysthe; Walker Krepps; Jamie Panthera; Keli Hippen; Stephen C Jameson; Jeffrey S Miller; Matthew A Cooper; Christopher J Farady; Takao Iwawaki; Jenny P-Y Ting; Jonathan S Serody; William J Murphy; Geoffrey R Hill; Peter J Murray; Vincenzo Bronte; David H Munn; Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2019-11-07       Impact factor: 25.476

7.  Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis.

Authors:  P Reddy; T Teshima; M Kukuruga; R Ordemann; C Liu; K Lowler; J L Ferrara
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

Review 8.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.

Authors:  Vincenzo Bronte; Sven Brandau; Shu-Hsia Chen; Mario P Colombo; Alan B Frey; Tim F Greten; Susanna Mandruzzato; Peter J Murray; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Paulo C Rodriguez; Antonio Sica; Viktor Umansky; Robert H Vonderheide; Dmitry I Gabrilovich
Journal:  Nat Commun       Date:  2016-07-06       Impact factor: 14.919

9.  miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate.

Authors:  Yun Ji; Jessica Fioravanti; Wei Zhu; Hongjun Wang; Tuoqi Wu; Jinhui Hu; Neal E Lacey; Sanjivan Gautam; John B Le Gall; Xia Yang; James D Hocker; Thelma M Escobar; Shan He; Stefania Dell'Orso; Nga V Hawk; Veena Kapoor; William G Telford; Luciano Di Croce; Stefan A Muljo; Yi Zhang; Vittorio Sartorelli; Luca Gattinoni
Journal:  Nat Commun       Date:  2019-05-14       Impact factor: 14.919

10.  The Nlrp3 inflammasome regulates acute graft-versus-host disease.

Authors:  Dragana Jankovic; Jayanthi Ganesan; Michael Bscheider; Natalie Stickel; Felix C Weber; Greta Guarda; Marie Follo; Dietmar Pfeifer; Aubry Tardivel; Kristina Ludigs; Abdellatif Bouazzaoui; Katrin Kerl; Julius C Fischer; Tobias Haas; Annette Schmitt-Gräff; Anand Manoharan; Leonard Müller; Jürgen Finke; Stefan F Martin; Oliver Gorka; Christian Peschel; Jürgen Ruland; Marco Idzko; Justus Duyster; Ernst Holler; Lars E French; Hendrik Poeck; Emmanuel Contassot; Robert Zeiser
Journal:  J Exp Med       Date:  2013-08-26       Impact factor: 14.307
  10 in total
  1 in total

1.  RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism.

Authors:  Man Liu; Hongxia Zhang; Lu Zhang; Xin Liu; Simin Zhou; Xiaoyi Wang; Weilong Zhong; Jie Zhang; Bangmao Wang; Jingwen Zhao; Lu Zhou
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.